VALERIE SENEY: Open Payments
NPI 1831219096 · FALL RIVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$745 in 22 payments from 12 companies in 2025. Trend: 2023 $787 · 2024 $341 · 2025 $745
Food & beverage: $745
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $195 |
| Indivior Inc. | 6 | $135 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $124 |
| Janssen Pharmaceuticals, Inc | 3 | $115 |
| ABBVIE INC. | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $20 |
| Alkermes, Inc. | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: SUBLOCADE, INGREZZA, CAPLYTA, SPRAVATO, VRAYLAR, REXULTI, VIVITROL, Qelbree.
Industry payments across MA — which companies pay providers there.
